Won Jong Jin

1.1k total citations
27 papers, 583 citations indexed

About

Won Jong Jin is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Won Jong Jin has authored 27 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 12 papers in Immunology and 11 papers in Molecular Biology. Recurrent topics in Won Jong Jin's work include Bone Metabolism and Diseases (11 papers), Immunotherapy and Immune Responses (10 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Won Jong Jin is often cited by papers focused on Bone Metabolism and Diseases (11 papers), Immunotherapy and Immune Responses (10 papers) and Cancer Immunotherapy and Biomarkers (10 papers). Won Jong Jin collaborates with scholars based in United States, South Korea and Puerto Rico. Won Jong Jin's co-authors include Hyunil Ha, Bong-Jun Kim, Zang Hee Lee, Jong-Ho Lee, Hong‐Hee Kim, Ha‐Neui Kim, Zachary S. Morris, Kyung-Ok Kim, Seungbok Lee and Hong-Hee Kim and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Science Translational Medicine.

In The Last Decade

Won Jong Jin

27 papers receiving 577 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Won Jong Jin United States 14 286 228 215 71 66 27 583
Dávid Győri Hungary 11 227 0.8× 244 1.1× 228 1.1× 46 0.6× 61 0.9× 16 526
Samia Q. Khan United States 9 193 0.7× 207 0.9× 316 1.5× 31 0.4× 82 1.2× 11 641
Kexing Fan China 10 149 0.5× 215 0.9× 223 1.0× 131 1.8× 60 0.9× 13 586
Yingjie Nie China 16 159 0.6× 291 1.3× 260 1.2× 59 0.8× 152 2.3× 41 714
Nivedita M. Ratnam United States 7 280 1.0× 188 0.8× 304 1.4× 89 1.3× 79 1.2× 8 714
Ryunosuke Muro Japan 14 164 0.6× 282 1.2× 290 1.3× 29 0.4× 59 0.9× 25 616
Bettina Grötsch Germany 9 102 0.4× 200 0.9× 174 0.8× 59 0.8× 93 1.4× 12 478
Huei‐Chi Wen United States 11 192 0.7× 181 0.8× 257 1.2× 143 2.0× 92 1.4× 12 1.1k
Chantal Mengus Switzerland 14 319 1.1× 209 0.9× 247 1.1× 29 0.4× 79 1.2× 22 648
Daria Briukhovetska Germany 6 273 1.0× 202 0.9× 366 1.7× 16 0.2× 60 0.9× 6 674

Countries citing papers authored by Won Jong Jin

Since Specialization
Citations

This map shows the geographic impact of Won Jong Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Won Jong Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Won Jong Jin more than expected).

Fields of papers citing papers by Won Jong Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Won Jong Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Won Jong Jin. The network helps show where Won Jong Jin may publish in the future.

Co-authorship network of co-authors of Won Jong Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Won Jong Jin. A scholar is included among the top collaborators of Won Jong Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Won Jong Jin. Won Jong Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jagodinsky, Justin C., Won Jong Jin, Paul A. Clark, et al.. (2024). Intratumoral radiation dose heterogeneity augments antitumor immunity in mice and primes responses to checkpoint blockade. Science Translational Medicine. 16(765). eadk0642–eadk0642. 22 indexed citations
2.
Jin, Won Jong, et al.. (2023). ATM inhibition augments type I interferon response and antitumor T-cell immunity when combined with radiation therapy in murine tumor models. Journal for ImmunoTherapy of Cancer. 11(9). e007474–e007474. 23 indexed citations
3.
Jin, Won Jong, Justin C. Jagodinsky, Paul A. Clark, et al.. (2023). NK cells propagate T cell immunity following in situ tumor vaccination. Cell Reports. 42(12). 113556–113556. 8 indexed citations
4.
O’Leary, Kathleen A., Amber M. Bates, Won Jong Jin, et al.. (2023). Estrogen receptor blockade and radiation therapy cooperate to enhance the response of immunologically cold ER+ breast cancer to immunotherapy. Breast Cancer Research. 25(1). 68–68. 9 indexed citations
5.
Pieper, Alexander, Alexander L. Rakhmilevich, Ravi B. Patel, et al.. (2021). Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice. Journal for ImmunoTherapy of Cancer. 9(6). e002715–e002715. 29 indexed citations
6.
Jagodinsky, Justin C., Paul A. Clark, Raghava N. Sriramaneni, et al.. (2021). A multipurpose brachytherapy catheter to enable intratumoral injection. Brachytherapy. 20(4). 900–910. 2 indexed citations
7.
Baniel, Claire, Peter M. Carlson, Won Jong Jin, et al.. (2020). In situ Vaccine Plus Checkpoint Blockade Induces Memory Humoral Response. Frontiers in Immunology. 11. 1610–1610. 12 indexed citations
8.
Jin, Won Jong, Amy K. Erbe, Raghava N. Sriramaneni, et al.. (2020). Tumor-Specific Antibody, Cetuximab, Enhances the In Situ Vaccine Effect of Radiation in Immunologically Cold Head and Neck Squamous Cell Carcinoma. Frontiers in Immunology. 11. 591139–591139. 21 indexed citations
9.
10.
Kim, Bong-Jun, Jong-Ho Lee, Won Jong Jin, et al.. (2018). Trapidil induces osteogenesis by upregulating the signaling of bone morphogenetic proteins. Cellular Signalling. 49. 68–78. 3 indexed citations
11.
Kim, Bong-Jun, Jong-Ho Lee, Won Jong Jin, et al.. (2018). JN-2, a C-X-C motif chemokine receptor 3 antagonist, ameliorates arthritis progression in an animal model. European Journal of Pharmacology. 823. 1–10. 16 indexed citations
12.
Kim, Bong-Jun, et al.. (2017). Pathogenic roles of CXCL10 signaling through CXCR3 and TLR4 in macrophages and T cells: relevance for arthritis. Arthritis Research & Therapy. 19(1). 163–163. 108 indexed citations
13.
Jin, Won Jong, Bong-Jun Kim, Jung‐Wook Kim, et al.. (2016). Supporting data for the effect of gamma-secretase inhibitors in osteoclast differentiation and spreading. Data in Brief. 7. 682–685. 1 indexed citations
14.
Jin, Won Jong, Bong-Jun Kim, Jung‐Wook Kim, et al.. (2016). Notch2 signaling promotes osteoclast resorption via activation of PYK2. Cellular Signalling. 28(5). 357–365. 18 indexed citations
15.
Jin, Won Jong, et al.. (2015). Myristoleic acid inhibits osteoclast formation and bone resorption by suppressing the RANKL activation of Src and Pyk2. European Journal of Pharmacology. 768. 189–198. 25 indexed citations
16.
Lee, Jong-Ho, Bong-Jun Kim, Won Jong Jin, et al.. (2014). Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms. Biochemical Pharmacology. 91(1). 51–60. 28 indexed citations
17.
Kim, Ha‐Neui, Jong-Ho Lee, Won Jong Jin, et al.. (2013). Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice. Biochemical Pharmacology. 86(6). 782–790. 20 indexed citations
18.
Lee, Jong-Ho, Ha‐Neui Kim, Kyung-Ok Kim, et al.. (2012). CXCL10 Promotes Osteolytic Bone Metastasis by Enhancing Cancer Outgrowth and Osteoclastogenesis. Cancer Research. 72(13). 3175–3186. 94 indexed citations
19.
Kim, Ha‐Neui, et al.. (2012). MS-275, a benzamide histone deacetylase inhibitor, prevents osteoclastogenesis by down-regulating c-Fos expression and suppresses bone loss in mice. European Journal of Pharmacology. 691(1-3). 69–76. 24 indexed citations
20.
Kim, Ha‐Neui, Jong-Ho Lee, Won Jong Jin, & Zang Hee Lee. (2012). α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption. Journal of Bone Metabolism. 19(2). 111–111. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dávid Győri Breakdown of academic impact, for papers by Samia Q. Khan Breakdown of academic impact, for papers by Kexing Fan Breakdown of academic impact, for papers by Yingjie Nie Breakdown of academic impact, for papers by Nivedita M. Ratnam Breakdown of academic impact, for papers by Ryunosuke Muro Breakdown of academic impact, for papers by Bettina Grötsch Breakdown of academic impact, for papers by Huei‐Chi Wen Breakdown of academic impact, for papers by Chantal Mengus Breakdown of academic impact, for papers by Daria Briukhovetska
Rankless by CCL
2026